Thomasj Schuetz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomasj schuetz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomasj Schuetz Today - Breaking & Trending Today

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives $9.05 Consensus Price Target from Analysts

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) has been given an average rating of “Buy” by the seven ratings firms that are presently covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price target among brokers that have updated their coverage on the stock in […] ....

Thomasj Schuetz , Squarepoint Ops , Geode Capital Management , Susquehanna International Group , Compass Therapeutics Inc , Compass Therapeutics , Get Rating , International Group , Street Group , Street Corp , Capital Management , Therapeutics Stock Down , Compass Therapeutics Daily , Nasdaq Cmpx ,

Short Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Declines By 5.9%

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 2,060,000 shares, a drop of 5.9% from the April 30th total of 2,190,000 shares. Approximately 3.1% of the company’s stock are sold short. Based […] ....

Thomasj Schuetz , Compass Therapeutics Company Profile , Monashee Investment Management , Jefferies Financial Group , Eventide Asset Management , Securities Exchange Commission , Vivo Capital , Compass Therapeutics Inc , Vanguard Group Inc , Compass Therapeutics , Get Rating , Financial Group , Exchange Commission , Asset Management , Investment Management , Vanguard Group , Compass Therapeutics Daily , Nasdaq Cmpx ,

Compass Therapeutics, Inc. (NASDAQ:CMPX) Sees Large Increase in Short Interest

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) saw a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 2,190,000 shares, an increase of 5.3% from the April 15th total of 2,080,000 shares. Based on an average daily trading volume, of 364,900 shares, the days-to-cover ratio […] ....

Stifel Nicolaus , Thomasj Schuetz , Vanguard Group Inc , Monashee Investment Management , Eventide Asset Management , Jefferies Financial Group , Securities Exchange Commission , Compass Therapeutics Inc , Vivo Capital , Compass Therapeutics , Get Rating , Therapeutics Stock Down , Financial Group , Exchange Commission , Asset Management , Investment Management , Vanguard Group , Compass Therapeutics Daily , Nasdaq Cmpx ,

Brokerages Set Compass Therapeutics, Inc. (NASDAQ:CMPX) Target Price at $9.05

Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) have earned an average recommendation of “Buy” from the seven ratings firms that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have covered the stock in the last […] ....

Stifel Nicolaus , Thomasj Schuetz , Compass Therapeutics Inc , Tower Research Capital , Jefferies Financial Group , Securities Exchange Commission , B Riley Wealth Advisors Inc , Compass Therapeutics , Get Rating , Financial Group , Exchange Commission , Research Capital , Street Group , Wealth Advisors , Exoduspoint Capital Management , Compass Therapeutics Daily , Nasdaq Cmpx ,

Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update

Initiated patient enrollment in a U.S. Phase 2/3 study of CTX-009 in patients with advanced biliary tract cancers . Top line data is expected in the first half of 2024Continue to enroll in a U.S.. | May 4, 2023 ....

United States , Japan General , New York , Danna Gifford , Richard Lindahl , Vered Bisker Leib , Thomasj Schuetz , Eli Lilly , Merck Co Inc , Merck Sharp Dohme , Development Pipeline , Compass Therapeutics Inc , University Of Virginia , Globenewswire Inc , Dartmouth College , Sprint Nextel Corporation , Audit Committee , Kansai Medical University , World Medical Innovation Forum Bank , Head Of Clinical Development , Senior Vice President , Emergent Biosolutions , Chief Executive , Chief Operating , Pipeline Update , Adaptive Simon Two Stage ,